Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EDD
11451
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$382M
| $114K | ﹤0.01% |
24,329
-434
| -2% | -$2.05K |
|
11452
PUT
ProShares Ultra Euro
ULE
$4.49M
| $114K | ﹤0.01% |
10,000
| – | – |
|
11453
Siebert Financial
SIEB
$81M
| $114K | ﹤0.01% |
37,757
+9,147
| +32% | +$25.2K |
|
|
OLO
11454
PUT
DELISTED
Olo Inc
OLO
| $114K | ﹤0.01% |
18,800
+4,100
| +28% | +$28.6K |
|
11455
PUT
Larimar Therapeutics
LRMR
$421M
| $114K | ﹤0.01% |
52,800
+39,300
| +291% | +$124K |
|
11456
EuroDry
EDRY
$141M
| $113K | ﹤0.01% |
+10,315
| New | +$114K |
|
11457
CALL
Microbot Medical
MBOT
$101M
| $113K | ﹤0.01% |
+74,900
| New | +$132K |
|
11458
PUT
UNIFI
UFI
$140M
| $113K | ﹤0.01% |
23,500
+12,600
| +116% | +$70.6K |
|
11459
Lifetime Brands
LCUT
$212M
| $113K | ﹤0.01% |
22,923
+4,513
| +25% | +$24.5K |
|
11460
Dyadic International
DYAI
$25.6M
| $113K | ﹤0.01% |
83,621
+8,321
| +11% | +$12.5K |
|
|
ERC
11461
Allspring Multi-Sector Income Fund
ERC
$259M
| $113K | ﹤0.01% |
12,241
-1,014
| -8% | -$9.38K |
|
11462
CALL
Riskified
RSKD
$808M
| $113K | ﹤0.01% |
+24,400
| New | +$123K |
|
11463
CALL
inTEST
INTT
$149M
| $113K | ﹤0.01% |
16,100
-19,900
| -55% | -$165K |
|
11464
ProShares UltraShort Health Care
RXD
$2.91M
| $112K | ﹤0.01% |
5,297
-4,237
| -44% | -$91.2K |
|
|
SNCR
11465
PUT
DELISTED
Synchronoss Technologies
SNCR
| $112K | ﹤0.01% |
+10,300
| New | +$102K |
|
11466
CALL
NRX Pharmaceuticals
NRXP
$157M
| $112K | ﹤0.01% |
+54,700
| New | +$154K |
|
|
ALLK
11467
DELISTED
Allakos
ALLK
| $111K | ﹤0.01% |
489,426
-87,046
| -15% | -$39.3K |
|
11468
DLH Holdings
DLHC
$64.9M
| $111K | ﹤0.01% |
+27,457
| New | +$168K |
|
11469
CALL
RF Industries
RFIL
$118M
| $111K | ﹤0.01% |
+23,700
| New | +$108K |
|
11470
CALL
Myomo
MYO
$65.7M
| $111K | ﹤0.01% |
23,100
+2,200
| +11% | +$12.5K |
|
|
IMMP
11471
CALL
Immutep
IMMP
$56.1M
| $111K | ﹤0.01% |
63,100
+45,700
| +263% | +$87.9K |
|
11472
CALL
10x Genomics
TXG
$8.45B
| $111K | ﹤0.01% |
12,700
-6,500
| -34% | -$81.9K |
|
|
KLRS
11473
Kalaris Therapeutics
KLRS
$97.6M
| $111K | ﹤0.01% |
13,796
+10,153
| +279% | +$99.4K |
|
|
WIMI
11474
PUT
WiMi Hologram Cloud
WIMI
$25.2M
| $111K | ﹤0.01% |
11,410
-7,590
| -40% | -$72.6K |
|
11475
PUT
Gold Royalty Corp
GROY
$795M
| $111K | ﹤0.01% |
76,800
+20,000
| +35% | +$27.2K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.